MedTrace Logo

Trial to Evaluate Topical C-82 in a Psoriasis Plaque Test

NCT02432027 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2017-08-17

No results posted yet for this study

Summary

Evaluate the effects of topical C-82 in a psoriasis plaque test.

Conditions

Interventions

DRUG

C-82 Topical Gel, Placebo

placebo

DRUG

C-82 Topical Gel, 1%

active

DRUG

Daivonex cream

comparator

DRUG

Diprosis gel

comparator

Sponsors & Collaborators

  • Prism Pharma Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Elisabeth Theis, MD · Klinische Forschung Schwerin GmbH

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2015-08-31
Completion
2015-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02432027 on ClinicalTrials.gov